Thursday, June 15, 2006

Herpes - NeurogesX Completes Enrollment in Pivotal Phase 3 Postherpetic


NeurogesX Completes Enrollment in Pivotal Phase 3 Postherpetic
International News Service, Australia - Jun 13, 2006 burning pain that develops in about 20 percent of patients after the herpes zoster rash (shingles) heals. The pain is often refractory to treatment and may

Starving cancer cells
Malaysia Star, Malaysia - Jun 10, 2006 side effects observed with other forms of cancer treatment. PI-88 too has more potential than just a cancer drug. Many viruses such as HIV, herpes and dengue

New data from the United States, Netherlands and United Kingdom
Therapeutics Daily (subscription) (press release), PA - Jun 13, 2006 on cancer treatment are outlined in reports from the United States, Netherlands and United Kingdom. Study 1: The efficacy of an oncolytic herpes simplex virus

Cervical cancer
About - News & Issues, NY - Jun 9, 2006 depending on its severity, can resolve without treatment, particularly in young Infections with genital herpes or chronic chlamydia infections, both sexually

Dr. Reddy's Has Initial Approval for Alzheimer's Drug (Update1)
Bloomberg - 6 hours ago Ltd., India's third-biggest drugmaker, secured initial approval from the US Food and Drug Administration to sell a drug used in the treatment of Alzheimer's

Herpes